PP
NYMX

Pacifica Partners’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Pacifica Partners’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,406
Closed -$3K – 415
2020
Q1 		$3K Hold
1,406
– – ﹤0.01% 318
2019
Q4 		$3K Buy
+1,406
New +$2.77K ﹤0.01% 321

Other funds holding NYMX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $25.2B AUM 30.31% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Pacifica Partners's NYMX Position: Q2 2020 in Review

Pacifica Partners sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2020, closing a stake of 1,406 shares — an estimated $3K sold.

Pacifica Partners first reported a position in NYMX in Q4 2019 and held it in 2 quarters. The position peaked at $3K in Q1 2020. 63 funds tracked by Wall St. Rank hold NYMX as of Q2 2020.

  • Pacifica Partners reported no remaining Nymox Pharmaceutical Corp position as of Q2 2020 after selling out during the quarter.
  • Pacifica Partners sold 1,406 Nymox Pharmaceutical Corp shares in Q2 2020, an estimated $3K.
  • Pacifica Partners first reported a position in Nymox Pharmaceutical Corp in Q4 2019 and held it in 2 quarters.
  • Pacifica Partners's Nymox Pharmaceutical Corp position peaked at $3K in Q1 2020.
  • 63 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2020.

Based on Pacifica Partners's 13F filing for Q2 2020, filed 15 Jul 2020.